Arch Biopartners Scientists Awarded Funding to Further Develop Brain Tumour Targeting Technology
June 23, 2011 14:14 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwire - June 23, 2011) - Arch Biopartners Inc. ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) and its subsidiary Arch Cancer Therapeutics ("ACT") today announced Arch...
Arch Scientists to Present at ESF-LFUI Conference in Austria
May 24, 2011 09:31 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwire - May 24, 2011) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) and its subsidiary Arch Biophysics Ltd today announced that Arch scientists Randall...
Arch Scientists Create New Bio-Organic Metal That Is Harder, Resists Corrosion
May 10, 2011 08:00 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwire - May 10, 2011) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) and its subsidiary Arch Biophysics Ltd today announced that Arch scientists have...
Arch Biopartners: Grants Stock Options to A Director
April 15, 2011 15:08 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwire - April 15, 2011) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) today announced it has granted 250,000 stock options with an exercise price of...
Arch Cancer Therapeutics' Technology Update
April 11, 2011 09:16 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwire - April 11, 2011) - Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTC:FOIFF) and its subsidiary Arch Cancer Therapeutics ("ACT") today announced Arch...